Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.00
+3.73 (1.82%)
AAPL  272.16
+5.98 (2.25%)
AMD  213.59
+16.99 (8.64%)
BAC  50.53
-0.54 (-1.06%)
GOOG  310.91
-0.78 (-0.25%)
META  639.00
+1.75 (0.28%)
MSFT  387.68
+3.21 (0.83%)
NVDA  192.51
+0.96 (0.50%)
ORCL  146.13
+4.82 (3.41%)
TSLA  408.55
+8.72 (2.18%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.